Impact of adding immunotherapy to chemotherapy for metastatic neuroendocrine bladder cancer in the National Cancer Database. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers ...
Extended dissection did not improve recurrence-free or overall survival, but it may have a bladder cancer-specific survival benefit possibly because it removes micrometastases. Extended lymph node ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results